Evidence map›Paper›PMID 36296655›Full record

ReviewMolecules (Basel, Switzerland)2022

Pharmacotherapeutics Applications and Chemistry of Chalcone Derivatives.

Jagjit Singh Dhaliwal, Said Moshawih, Khang Wen Goh, Mei Jun Loy, Md Sanower Hossain, Andi Hermansyah, Vijay Kotra, Nurolaini Kifli, Hui Poh Goh, Sachinjeet Kaur Sodhi Dhaliwal and 2 more

Open access · goldAbstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
11.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 115 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. IMolecules (Basel, Switzerland) · 2026
    Article
  6. Review
  7. Article
  8. Polyphenolic compounds inFrontiers in pharmacology · 2026
    Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Chalcones as Emerging Antibacterial Scaffolds: A Mini Review.Mini reviews in medicinal chemistry · 2025
    Review
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 3 countries.

Jagjit Singh DhaliwalPAPRSB Institute of Health Sciences, Universiti Brunei Darussalam, Gadong BE1410, Brunei.ORCID 0000-0002-3357-388X
Said MoshawihPAPRSB Institute of Health Sciences, Universiti Brunei Darussalam, Gadong BE1410, Brunei.ORCID 0000-0003-4840-0460
Khang Wen GohFaculty of Data Science and Information Technology, INTI International University, Nilai 71800, Malaysia.ORCID 0000-0001-6686-7019
Mei Jun LoyFaculty of Engineering, Universiti Teknologi Malaysia, Skudai 81300, Malaysia.
Md Sanower HossainCentre for Sustainability of Ecosystem and Earth Resources (Pusat ALAM), Universiti Malaysia Pahang, Kuantan 26300, Malaysia.ORCID 0000-0001-5686-2943
Andi HermansyahDepartment of Pharmacy Practice, Faculty of Pharmacy, Universitas Airlangga, Surabaya 60115, Indonesia.ORCID 0000-0002-9716-3126
Vijay KotraFaculty of Pharmacy, Quest International University, Ipoh 30250, Malaysia.ORCID 0000-0002-2043-4928
Nurolaini KifliPAPRSB Institute of Health Sciences, Universiti Brunei Darussalam, Gadong BE1410, Brunei.ORCID 0000-0002-8817-7956
Hui Poh GohPAPRSB Institute of Health Sciences, Universiti Brunei Darussalam, Gadong BE1410, Brunei.ORCID 0000-0002-0480-399X
Sachinjeet Kaur Sodhi DhaliwalPAPRSB Institute of Health Sciences, Universiti Brunei Darussalam, Gadong BE1410, Brunei.
Hayati YassinFaculty of Integrated Technologies, Universiti Brunei Darussalam, Gadong BE1410, Brunei.
Long Chiau MingPAPRSB Institute of Health Sciences, Universiti Brunei Darussalam, Gadong BE1410, Brunei.ORCID 0000-0002-6971-1383
Universiti Brunei Darussalam · BNAirlangga University · IDINTI International University · MYQuest International University Perak · MYUniversiti Malaysia Pahang Al-Sultan Abdullah · MYUniversity of Technology Malaysia · MY

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chalcones have been well examined in the extant literature and demonstrated antibacterial, antifungal, anti-inflammatory, and anticancer properties. A detailed evaluation of the purported health benefits of chalcone and its derivatives, including molecular mechanisms of pharmacological activities, can be further explored. Therefore, this review aimed to describe the main characteristics of chalcone and its derivatives, including their method synthesis and pharmacotherapeutics applications with molecular mechanisms. The presence of the reactive α,β-unsaturated system in the chalcone's rings showed different potential pharmacological properties, including inhibitory activity on enzymes, anticancer, anti-inflammatory, antibacterial, antifungal, antimalarial, antiprotozoal, and anti-filarial activity. Changing the structure by adding substituent groups to the aromatic ring can increase potency, reduce toxicity, and broaden pharmacological action. This report also summarized the potential health benefits of chalcone derivatives, particularly antimicrobial activity. We found that several chalcone compounds can inhibit diverse targets of antibiotic-resistance development pathways; therefore, they overcome resistance, and bacteria become susceptible to antibacterial compounds. A few chalcone compounds were more active than conventional antibiotics, like vancomycin and tetracycline. On another note, a series of pyran-fused chalcones and trichalcones can block the NF-B signaling complement system implicated in inflammation, and several compounds demonstrated more potent lipoxygenase inhibition than NSAIDs, such as indomethacin. This report integrated discussion from the domains of medicinal chemistry, organic synthesis, and diverse pharmacological applications, particularly for the development of new anti-infective agents that could be a useful reference for pharmaceutical scientists.

Indexed as

Anti-Infective AgentsAntimalarialsChalconeChalconesAnti-Bacterial AgentsAntifungal AgentsAnti-Inflammatory AgentsAnti-Inflammatory Agents, Non-SteroidalIndomethacinLipoxygenasesPharmaceutical PreparationsStructure-Activity RelationshipTetracyclinesVancomycinAnti-Bacterial AgentsAntifungal AgentsAnti-Infective AgentsAnti-Inflammatory AgentsAnti-Inflammatory Agents, Non-SteroidalAntimalarialsChalconeChalconesIndomethacinLipoxygenasesPharmaceutical PreparationsTetracyclinesVancomycinantimicrobial agentcancercardiovascular diseasehealth benefitsinfectious diseasepharmacology

Identifiers

PMID36296655
PMCPMC9607940
OpenAlexW4306847677

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.